BR102012021469A2 - PROCEDURE FOR OBTAINING AND USING THE HONEY EXTRACT FROM THE IRON BEE SPECIES Tetragonisca angustula Latreille, 1811 (Apidae, Meliponini) - Google Patents
PROCEDURE FOR OBTAINING AND USING THE HONEY EXTRACT FROM THE IRON BEE SPECIES Tetragonisca angustula Latreille, 1811 (Apidae, Meliponini)Info
- Publication number
- BR102012021469A2 BR102012021469A2 BRBR102012021469-5A BR102012021469A BR102012021469A2 BR 102012021469 A2 BR102012021469 A2 BR 102012021469A2 BR 102012021469 A BR102012021469 A BR 102012021469A BR 102012021469 A2 BR102012021469 A2 BR 102012021469A2
- Authority
- BR
- Brazil
- Prior art keywords
- angustula
- honey
- tetragonisca
- meliponini
- latreille
- Prior art date
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
PROCESSO DE OBTENÇÃO E USO DO EXTRATO DO MEL PROVENIENTE DA ESPÉCIE DE ABELHA SEM FERRÃO TETRAGONISCA ANGUSTULA LATREILLE, 1811 (APIDAE, MELIPONINI). O uso de produtos apícolas tem sido recentemente a foco das atenções como uma forma de medicina preventiva e familiar para o tratamento de certas condições e doenças bem como a promoção de saúde. Estudos demonstram que o mel tem propriedades antioxidante e antimicrobiana, sendo utilizado na estimulação da cicatrização de ferimentos e queimaduras e, também, no tratamento de úlceras gástricas. Dessa forma, o uso do extrato e frações do mel da espécie de abelha sem ferrão tetragonisca angustula latreille, 1811 (apidae, meliponini) com finalidade antimicrobiana e antioxidante apresenta-se como uma alternativa promissora. A presente invenção refere-se à identificação das propriedades medicinal, nutricional, farmacêutica, cosmética, alelopática, imunológica, anti-inflamatória, antimicrobiana e antioxidante, no campo humano, veterinário, agronômico, alimentício e ambiental do extrato e frações do mel da espécie de abelha sem ferrão T. angustula, obtidos por extração utilizando a resina amberlite<32> XAD-2. A invenção está relacionada também às formas farmacêuticas e dosagens galênicas líquidas, semi-sólidas e sólidas tais como soluções,suspensões, emulsões, aerossol, pós, cápsulas, tabletes, comprimidos e drágeas, todas as quais contendo prepaarções originárias do extrato e frações do mel da espécie de abelha sem ferrão t. angustula, obtidos pelo processo mencionado acima.PROCEDURE FOR OBTAINING AND USING HONEY EXTRACTS FROM THE TETRAGONISCA ANGUSTULA LATREILLE BEE SPECIES, 1811 (APIDAE, MELIPONINI). The use of bee products has recently been the focus of attention as a form of preventive and family medicine for the treatment of certain conditions and diseases as well as health promotion. Studies show that honey has antioxidant and antimicrobial properties, being used in the stimulation of wound healing and burns, and also in the treatment of gastric ulcers. Thus, the use of honey extract and fractions of the stingless bee species tetragonisca angustula latreille, 1811 (apidae, meliponini) for antimicrobial and antioxidant purposes is a promising alternative. The present invention relates to the identification of the medicinal, nutritional, pharmaceutical, cosmetic, allelopathic, immunological, anti-inflammatory, antimicrobial and antioxidant properties in the human, veterinary, agronomic, food and environmental field of honey extract and fractions of the species. stingless bee T. angustula, obtained by extraction using amberlite resin <32> XAD-2. The invention also relates to solid, semi-solid and solid dosage forms and dosage forms such as solutions, suspensions, emulsions, aerosols, powders, capsules, tablets, tablets and dragees, all of which contain preparations originating from honey extract and fractions. of the stingless bee species t. angustula, obtained by the process mentioned above.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRBR102012021469-5A BR102012021469A2 (en) | 2012-08-27 | 2012-08-27 | PROCEDURE FOR OBTAINING AND USING THE HONEY EXTRACT FROM THE IRON BEE SPECIES Tetragonisca angustula Latreille, 1811 (Apidae, Meliponini) |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRBR102012021469-5A BR102012021469A2 (en) | 2012-08-27 | 2012-08-27 | PROCEDURE FOR OBTAINING AND USING THE HONEY EXTRACT FROM THE IRON BEE SPECIES Tetragonisca angustula Latreille, 1811 (Apidae, Meliponini) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR102012021469A2 true BR102012021469A2 (en) | 2014-06-10 |
Family
ID=50877843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRBR102012021469-5A BR102012021469A2 (en) | 2012-08-27 | 2012-08-27 | PROCEDURE FOR OBTAINING AND USING THE HONEY EXTRACT FROM THE IRON BEE SPECIES Tetragonisca angustula Latreille, 1811 (Apidae, Meliponini) |
Country Status (1)
| Country | Link |
|---|---|
| BR (1) | BR102012021469A2 (en) |
-
2012
- 2012-08-27 BR BRBR102012021469-5A patent/BR102012021469A2/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015014372A8 (en) | autotaxin inhibitors, their uses, and pharmaceutical composition and combination ". | |
| MX2011013150A (en) | Pharmaceutical composition for use in medical and veterinary ophthalmology. | |
| BR112015029897A2 (en) | solid composition for oral administration containing ibandronic acid or a pharmaceutically acceptable salt thereof and vitamin d and process for obtaining said composition | |
| CL2018003827A1 (en) | New extract of achene silybum marianum and uses of it in dermatology and dermocosmetics. | |
| ES2597784T3 (en) | Combination of valerian root extract and lavender oil to use in the treatment of sleep disorders | |
| Sim et al. | Acute oral toxicity of Pereskia bleo and Pereskia grandifolia in mice | |
| Putra et al. | Hematopoiesis activity of Sambucus javanica on chloramphenicol-induced aplastic anemia mouse model | |
| BR112017008734A2 (en) | A curative medicine, a preventive medicine, and a food constituent for-prevention for medical treatment of a disease resulting from lack of the Tou protein production catalyst and the Tou protein | |
| BR102012021469A2 (en) | PROCEDURE FOR OBTAINING AND USING THE HONEY EXTRACT FROM THE IRON BEE SPECIES Tetragonisca angustula Latreille, 1811 (Apidae, Meliponini) | |
| CN105769629A (en) | Breast-enlarging essential oil | |
| BR102012021466A2 (en) | PROCEDURE FOR OBTAINING AND USING HONEY EXTRACTS FROM THE IRON-FREE BEE KIND BICOLOR LEPELETIER, 1836 (APIDAE, MELIPONINI) | |
| BR102012021467A2 (en) | PROCEDURE FOR OBTAINING AND USING HONEY EXTRACT FROM THE IRON-FREE BEE KIND MELIPONA QUADRIFASCIATA LEPELETIER, 1836 (APIDAE, MELIPONINI) | |
| BR102012021468A2 (en) | PROCESS FOR OBTAINING AND USING THE EXTRACT OF HONEY FROM THE IRONED BEE SPECIES SCAPTOTRIGONA BIPUNCTATA LEPELETIER. 1836 (APIDAE, MELIPONINI) | |
| Kashani et al. | Teratogenic effects of Origanum Vulgare extract in mice fetals. | |
| CN103446517B (en) | Traditional Chinese medicine effective part composition for removing dandruff and preparation method thereof | |
| Olczyk et al. | Influence of Temperature on Free Radical Generation in Propolis‐Containing Ointments | |
| BR102012021465A2 (en) | PROCEDURE FOR OBTAINING AND USING HONEY EXTRACTS FROM THE IRONED BEE SPECIES TETRAGONA CLAVIPES FABRICIUS, 1804 (APIDAE, MELIPONINI) | |
| Chioma | Anti-inflammatory and anti-oxidant activities of methanol extract of Baphia nitida | |
| Kacemi et al. | Bee Pollen as a Source of Pharmaceuticals: Where Are We Now? | |
| SG11201806628UA (en) | New bi-aromatic propynyl compounds, pharmaceutical and cosmetic compositions containing them and uses thereof | |
| Ozioma et al. | Platelet aggregation effect of Corchorus olitorus extract as an index of managing blood clotting disorders | |
| Hawilo et al. | Prospects of development of new herbal drugs | |
| WO2017014162A8 (en) | AMYLOID β FIBRIL DECOMPOSING AGENT, AND THERAPEUTIC OR PREVENTIVE AGENT AND THERAPEUTIC OR PREVENTIVE FOOD COMPOSITION FOR DISEASES CAUSED BY AMYLOID β FIBRIL FORMATION | |
| Alizadeh et al. | Study of antioxidant activity and total phenolic content of 22 plants from Compositae family | |
| Shahmohammadi | Evaluation of sedative-hypnotic effect of Myrtus communis L. aqueous extract in mice |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B03A | Publication of an application: publication of a patent application or of a certificate of addition of invention | ||
| B15K | Others concerning applications: alteration of classification |
Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 35/64, A23L 1/08, A61P 31/04, A61P 39/06 Ipc: A61K 35/64 (2006.01), A23L 1/08 (2006.01), A61P 31 |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law | ||
| B06F | Objections, documents and/or translations needed after an examination request according art. 34 industrial property law | ||
| B15K | Others concerning applications: alteration of classification |
Ipc: A61K 35/644 (2015.01), A23L 21/25 (2016.01), A61P |
|
| B07E | Notice of approval relating to section 229 industrial property law |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06V | Preliminary requirement: requests without searches performed by other patent offices: suspension of the patent application procedure | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |